These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19392867)

  • 41. The prognostic significance of pretreatment leukocytosis in patients with anal cancer treated with radical chemoradiotherapy or radiotherapy.
    Banerjee R; Roxin G; Eliasziw M; Joseph K; Maclean A; Buie WD; Doll C
    Dis Colon Rectum; 2013 Sep; 56(9):1036-42. PubMed ID: 23929012
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anal carcinoma or "just hemorrhoids"?
    Winburn GB
    Am Surg; 2001 Nov; 67(11):1048-58. PubMed ID: 11730221
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.
    Resino S; Resino R; Micheloud D; Gurbindo Gutiérrez D; Léon JA; Ramos JT; Ciria L; de José I; Mellado J; Muñoz-Fernández A;
    Clin Infect Dis; 2006 Mar; 42(6):862-9. PubMed ID: 16477566
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy.
    Piketty C; Selinger-Leneman H; Grabar S; Duvivier C; Bonmarchand M; Abramowitz L; Costagliola D; Mary-Krause M;
    AIDS; 2008 Jun; 22(10):1203-11. PubMed ID: 18525266
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness.
    Ferrigno R; Nakamura RA; Dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV; Filho WJ; Lopes A
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1136-42. PubMed ID: 15752894
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy.
    Piketty C; Darragh TM; Heard I; Da Costa M; Bruneval P; Kazatchkine MD; Palefsky JM
    Sex Transm Dis; 2004 Feb; 31(2):96-9. PubMed ID: 14743072
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcome and prognosis factors in HIV-infected hemodialysis patients.
    Tourret J; Tostivint I; du Montcel ST; Bragg-Gresham J; Karie S; Vigneau C; Guiard-Schmid JB; Deray G; Bagnis CI
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1241-7. PubMed ID: 17699354
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
    Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
    Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oncologic outcomes of salvage surgery for epidermoid carcinoma of the anus initially managed with combined modality therapy.
    Akbari RP; Paty PB; Guillem JG; Weiser MR; Temple LK; Minsky BD; Saltz L; Wong WD
    Dis Colon Rectum; 2004 Jul; 47(7):1136-44. PubMed ID: 15164245
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The prognosis of highly active antiretroviral therapy (HAART) treated HIV infected patients in Serbia, related to the time of treatment initiation.
    Jevtović Dj; Salemović D; Ranin J; Dulović O; Ilić D; Brmbolić B
    J Clin Virol; 2010 Feb; 47(2):131-5. PubMed ID: 20006540
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Concurrent concentrated radio-chemotherapy of epidermoid cancer of the esophagus. Long-term results of a phase II national multicenter trial in 122 non-operable patients (FFCD 8803)].
    Seitz JF; Milan C; Giovannini M; Dumas F; Cauvin JM; Conroy T; François E; Renard P; Votte-Lambert A; Paillot B; Bedenne L; ;
    Gastroenterol Clin Biol; 2000 Feb; 24(2):201-10. PubMed ID: 12687962
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003].
    Jacomet C; Lesens O; Villemagne B; Darcha C; Tournilhac O; Henquell C; Cormerais L; Gourdon F; Peigue-Lafeuille H; Travade P; Beytout J; Laurichesse H
    Med Mal Infect; 2006 Mar; 36(3):157-62. PubMed ID: 16503104
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy.
    Lim ST; Karim R; Tulpule A; Nathwani BN; Levine AM
    J Clin Oncol; 2005 Nov; 23(33):8477-82. PubMed ID: 16230675
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anal carcinoma in HIV-infected patients in the era of antiretroviral therapy: a comparative study.
    Munoz-Bongrand N; Poghosyan T; Zohar S; Gerard L; Chirica M; Quero L; Gornet JM; Cattan P
    Dis Colon Rectum; 2011 Jun; 54(6):729-35. PubMed ID: 21552058
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outcome of HIV-infected patients with invasive squamous-cell carcinoma of the anal canal in the era of highly active antiretroviral therapy.
    Stadler RF; Gregorcyk SG; Euhus DM; Place RJ; Huber PJ; Simmang CL
    Dis Colon Rectum; 2004 Aug; 47(8):1305-9. PubMed ID: 15484343
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the french hospital database on HIV.
    Piketty C; Selinger-Leneman H; Bouvier AM; Belot A; Mary-Krause M; Duvivier C; Bonmarchand M; Abramowitz L; Costagliola D; Grabar S
    J Clin Oncol; 2012 Dec; 30(35):4360-6. PubMed ID: 23091098
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management of anal cancer in the HIV-positive population.
    Kauh J; Koshy M; Gunthel C; Joyner MM; Landry J; Thomas CR
    Oncology (Williston Park); 2005 Nov; 19(12):1634-8; discussion 1638-40, 1645 passim. PubMed ID: 16396154
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outcome analysis of HIV-positive patients with anal squamous cell carcinoma.
    Place RJ; Gregorcyk SG; Huber PJ; Simmang CL
    Dis Colon Rectum; 2001 Apr; 44(4):506-12. PubMed ID: 11330577
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic and Predictive Clinicopathologic Factors of Squamous Anal Canal Cancer in HIV-Positive and HIV-Negative Patients: Does HAART Influence Outcomes?
    Pappou EP; Magruder JT; Fu T; Hicks CW; Herman JM; Fang S; Wick EC; Safar B; Gearhart SL; Efron JE
    World J Surg; 2018 Mar; 42(3):876-883. PubMed ID: 28948325
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Local tumor control and toxicity in HIV-associated anal carcinoma treated with radiotherapy in the era of antiretroviral therapy.
    Oehler-Jänne C; Seifert B; Lütolf UM; Ciernik IF
    Radiat Oncol; 2006 Aug; 1():29. PubMed ID: 16916475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.